What is Aptargroup, Inc. share price today?

Aptargroup, Inc. (ATR) share price today is {{live_price}}.

Can Indians buy Aptargroup, Inc. shares?

Yes, Indians can invest in the Aptargroup, Inc. (ATR) from India. With INDmoney, you can buy Aptargroup, Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Aptargroup, Inc. at zero transaction cost.

How can I buy Aptargroup, Inc. shares from India?

It is very easy to buy Aptargroup, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptargroup, Inc. be purchased?

Yes, you can buy fractional shares of Aptargroup, Inc. with INDmoney app.

What are the documents required to start investing in Aptargroup, Inc. stocks?

To start investing in Aptargroup, Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aptargroup, Inc.

Today’s highest price of Aptargroup, Inc. (ATR) is {{1_rba_end}}. Today’s lowest price of Aptargroup, Inc. (ATR) is {{1_rba_st}}.

What is today's market capitalisation of Aptargroup, Inc.

Today's market capitalisation of Aptargroup, Inc. ATR is 11.2B

What is the 52 Week High and Low Range of Aptargroup, Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Aptargroup, Inc. is down from its 52 Week High?

Aptargroup, Inc. (ATR) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Aptargroup, Inc. is up from its 52 Week low?

Aptargroup, Inc. (ATR) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Aptargroup, Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Aptargroup, Inc.

Mr. Stephan B. Tanda is the current Chief Executive Officer (CEO) of Aptargroup, Inc..

Home>
US Stocks>
Aptargroup, Inc.

Aptargroup, Inc. (ATR)

$169.88

+1.15

(+0.68%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

$167.74
$170.23
$169.88
1.26%
Downside
Day's Volatility :1.46%
Upside
0.21%
$122.29
$178.03
$169.88
28.01%
Downside
52 Weeks Volatility :31.31%
Upside
4.58%

Returns

Period	Aptargroup, Inc.	Sector (Materials)	Index (Russel 2000)
3 Months	14.02%	2.2%	0.0%
6 Months	14.17%	2.4%	0.0%
1 Year	32.13%	15.8%	0.0%
3 Years	31.89%	5.8%	-24.1%

Highlights

Market Capitalization	11.2B
Book Value	$38.18
Dividend Share	1.68
Dividend Yield	1.08%
Earnings Per Share (EPS)	5.03
PE Ratio	33.54
PEG Ratio	2.62
Wall Street Target Price	188.0

Profit Margin	9.4%
Operating Margin TTM	15.66%

Return On Assets TTM	7.01%
Return On Equity TTM	14.08%

Revenue TTM	3.6B
Revenue Per Share TTM	54.01
Quarterly Revenue Growth YOY	1.7999999999999998%
Gross Profit TTM	1.2B
EBITDA	761.1M
Diluted Eps TTM	5.03
Quarterly Earnings Growth YOY	0.18

EPS Estimate Current Year	5.4
EPS Estimate Next Year	5.93
EPS Estimate Current Quarter	1.42
EPS Estimate Next Quarter	1.31

Analyst Recommendation

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Aptargroup, Inc.(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 10.67%

Current $169.88

Target $188.00

Company Financials

	FY18	Y/Y Change
Revenue	2.8B	↑ 11.97%
Net Income	194.7M	↓ 11.49%
Net Profit Margin	7.04%	↓ 1.87%

	FY19	Y/Y Change
Revenue	2.9B	↑ 3.44%
Net Income	242.2M	↑ 24.37%
Net Profit Margin	8.47%	↑ 1.43%

	FY20	Y/Y Change
Revenue	2.9B	↑ 2.43%
Net Income	214.0M	↓ 11.63%
Net Profit Margin	7.31%	↓ 1.16%

	FY21	Y/Y Change
Revenue	3.2B	↑ 10.17%
Net Income	244.1M	↑ 14.04%
Net Profit Margin	7.56%	↑ 0.25%

	FY22	Y/Y Change
Revenue	3.3B	↑ 2.94%
Net Income	239.3M	↓ 1.97%
Net Profit Margin	7.2%	↓ 0.36%

	FY23	Y/Y Change
Revenue	3.5B	↑ 4.97%
Net Income	284.5M	↑ 18.89%
Net Profit Margin	8.16%	↑ 0.96%

	Q2 FY23	Q/Q Change
Revenue	895.9M	↑ 4.17%
Net Income	83.1M	↑ 51.69%
Net Profit Margin	9.27%	↑ 2.9%

	Q3 FY23	Q/Q Change
Revenue	893.0M	↓ 0.32%
Net Income	84.3M	↑ 1.47%
Net Profit Margin	9.44%	↑ 0.17%

	Q4 FY23	Q/Q Change
Revenue	838.5M	↓ 6.1%
Net Income	62.4M	↓ 26.03%
Net Profit Margin	7.44%	↓ 2.0%

	Q1 FY24	Q/Q Change
Revenue	915.4M	↑ 9.18%
Net Income	83.1M	↑ 33.28%
Net Profit Margin	9.08%	↑ 1.64%

	Q2 FY24	Q/Q Change
Revenue	910.1M	↓ 0.59%
Net Income	90.5M	↑ 8.84%
Net Profit Margin	9.94%	↑ 0.86%

	Q3 FY24	Q/Q Change
Revenue	909.3M	↓ 0.08%
Net Income	100.0M	↑ 10.6%
Net Profit Margin	11.0%	↑ 1.06%

	FY18	Y/Y Change
Total Assets	3.4B	↑ 7.59%
Total Liabilities	2.0B	↑ 6.97%

	FY19	Y/Y Change
Total Assets	3.6B	↑ 5.46%
Total Liabilities	2.0B	↑ 1.79%

	FY20	Y/Y Change
Total Assets	4.0B	↑ 12.01%
Total Liabilities	2.1B	↑ 7.51%

	FY21	Y/Y Change
Total Assets	4.1B	↑ 3.79%
Total Liabilities	2.2B	↑ 0.82%

	FY22	Y/Y Change
Total Assets	4.2B	↑ 1.5%
Total Liabilities	2.1B	↓ 1.0%

	FY23	Y/Y Change
Total Assets	4.5B	↑ 5.91%
Total Liabilities	2.1B	↓ 0.22%

	Q2 FY23	Q/Q Change
Total Assets	4.3B	↑ 1.04%
Total Liabilities	2.2B	↓ 0.72%

	Q3 FY23	Q/Q Change
Total Assets	4.3B	↓ 1.14%
Total Liabilities	2.1B	↓ 3.46%

	Q4 FY23	Q/Q Change
Total Assets	4.5B	↑ 3.58%
Total Liabilities	2.1B	↑ 2.21%

	Q1 FY24	Q/Q Change
Total Assets	4.4B	↓ 0.33%
Total Liabilities	2.1B	↓ 2.65%

	Q2 FY24	Q/Q Change
Total Assets	4.5B	↑ 0.36%
Total Liabilities	2.0B	↓ 1.5%

	Q3 FY24	Q/Q Change
Total Assets	4.6B	↑ 3.86%
Total Liabilities	2.1B	↑ 1.4%

	FY18	Y/Y Change
Operating Cash Flow	313.6M	↓ 3.42%
Investing Cash Flow	-735.5M	↑ 227.16%
Financing Cash Flow	-14.9M	↓ 112.96%

	FY19	Y/Y Change
Operating Cash Flow	514.5M	↑ 64.03%
Investing Cash Flow	-336.3M	↓ 54.28%
Financing Cash Flow	-197.1M	↑ 1225.54%

	FY20	Y/Y Change
Operating Cash Flow	570.2M	↑ 10.83%
Investing Cash Flow	-452.0M	↑ 34.41%
Financing Cash Flow	-73.7M	↓ 62.6%

	FY21	Y/Y Change
Operating Cash Flow	363.4M	↓ 36.26%
Investing Cash Flow	-457.2M	↑ 1.16%
Financing Cash Flow	-81.5M	↑ 10.57%

	FY22	Y/Y Change
Operating Cash Flow	478.6M	↑ 31.69%
Investing Cash Flow	-295.6M	↓ 35.34%
Financing Cash Flow	-162.1M	↑ 98.85%

	Q2 FY23	Q/Q Change
Operating Cash Flow	83.9M	↓ 14.66%
Investing Cash Flow	-163.6M	↑ 83.46%
Financing Cash Flow	-11.0M	↓ 55.74%

	Q3 FY23	Q/Q Change
Operating Cash Flow	173.4M	↑ 106.68%
Investing Cash Flow	-239.3M	↑ 46.29%
Financing Cash Flow	-58.2M	↑ 429.4%

Technicals Summary

Sell

Neutral

Buy

Aptargroup, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptargroup, Inc.	2.45%	14.17%	32.13%	31.89%	54.27%
Intuitive Surgical, Inc.	6.4%	37.35%	74.36%	61.6%	190.06%
Resmed Inc.	1.51%	11.6%	59.62%	-5.3%	67.71%
Becton, Dickinson And Company	-5.95%	-3.84%	-4.79%	-8.09%	-9.78%
West Pharmaceutical Services Inc	12.04%	-4.01%	-8.63%	-26.69%	119.18%
Alcon Ag	-9.58%	-5.71%	17.48%	6.3%	50.86%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptargroup, Inc.	33.54	33.54	2.62	5.4	0.14	0.07	0.01	38.18
Intuitive Surgical, Inc.	86.97	86.97	4.02	6.85	0.16	0.08	NA	43.75
Resmed Inc.	32.04	32.04	1.83	7.71	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	37.57	37.57	1.03	13.11	0.06	0.03	0.02	89.5
West Pharmaceutical Services Inc	46.31	46.31	5.82	6.66	0.18	0.1	0.0	37.96
Alcon Ag	36.54	36.54	3.09	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptargroup, Inc.	Buy	$11.2B	54.27%	33.54	9.4%
Intuitive Surgical, Inc.	Buy	$193.0B	190.06%	86.97	28.51%
Resmed Inc.	Buy	$35.5B	67.71%	32.04	23.15%
Becton, Dickinson And Company	Buy	$64.3B	-9.78%	37.57	7.13%
West Pharmaceutical Services Inc	Buy	$22.6B	119.18%	46.31	17.37%
Alcon Ag	Buy	$42.3B	50.86%	36.54	11.89%

Insights on Aptargroup, Inc.

Decreasing Revenue
Revenue is down for the last 3 quarters, 915.44M → 909.29M (in $), with an average decrease of 0.3% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, 62.35M → 100.03M (in $), with an average increase of 14.2% per quarter
Vs ISRG
In the last 1 year, Intuitive Surgical, Inc. has given 74.4% return, outperforming this stock by 42.3%
Vs ISRG
In the last 3 years, Intuitive Surgical, Inc. has given 61.6% return, outperforming this stock by 29.7%

Institutional Holdings

Morgan Stanley - Brokerage Accounts
14.82%
Vanguard Group Inc
10.74%
BlackRock Inc
9.25%
State Farm Mutual Automobile Ins Co
7.13%
State Street Corp
4.32%
Victory Capital Management Inc.
3.17%

Corporate Announcements

Aptargroup, Inc. Dividends March,2024
In the quarter ending March,2024. Aptargroup, Inc. has declared dividend of $0.41
Read More

Organization	Aptargroup, Inc.
Employees	13000
CEO	Mr. Stephan B. Tanda
Industry	Process Industries

Aptargroup, Inc. (ATR)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Decreasing Revenue

Increasing Net Profit

Vs ISRG

Vs ISRG

Institutional Holdings

Corporate Announcements

Aptargroup, Inc. Dividends March,2024

Company Information

Discover More

FAQs